Grace Water Med Public Company Limited (GWM25) kicked off its trading on the LiVEx Exchange, a new market for SMEs and Startups, at THB 3 per share, up by THB 1 or 50% from the initial public offering (IPO) price of THB 2. This highlights investors’ confidence in the company’s fundamentals and growth potential.
Mr. Thongchai Pami, Chief Executive Officer of GWM25, stated that the positive market response on the first day affirms investors’ trust. He also added that in 2025, the company expects revenue of no less than THB 180 million and anticipates an average annual growth rate of at least 10%. GWM25 is preparing to list on the Market for Alternative Investment (mai) within three years to attract more institutional investors, both domestically and internationally.
Proceeds from the capital raising will be used to expand the dialysis business and reverse osmosis (RO) system, as well as to repay debt and provide working capital. This will foster stable growth as GWM25’s business aligns with Thailand’s demographic trend toward an aging society, leading to an increasing number of kidney disease patients. The company also benefits from government policy subsidizing dialysis treatment at THB 1,500 per patient per session, with more than THB 20 billion allocated for this in the past year.
GWM25 operates a comprehensive kidney care business, covering the production and distribution of dialysis solutions and disinfectants for dialysis units, sales and rental of medical supplies, design and installation of RO systems with maintenance services, and the sale of supplements and medical-grade cosmetics for kidney patients. These business operations highlight GWM25’s commitment to improving patient quality of life and creating long-term business growth opportunities.
